150 related articles for article (PubMed ID: 9290398)
1. Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group.
Birkhead JS
Heart; 1997 Jul; 78(1):28-33. PubMed ID: 9290398
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.
French JK; Williams BF; Hart HH; Wyatt S; Poole JE; Ingram C; Ellis CJ; Williams MG; White HD
BMJ; 1996 Jun; 312(7047):1637-41. PubMed ID: 8664716
[TBL] [Abstract][Full Text] [Related]
3. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
Ketley D; Woods KL
Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
[TBL] [Abstract][Full Text] [Related]
4. [What thrombolytic rate can be realized in acute myocardial infarct? Results of the Oltner Heart Emergency Study].
Gaillet R; Saner H; Pfister R; Pirovino M
Schweiz Med Wochenschr; 1998 May; 128(20):775-83. PubMed ID: 9642753
[TBL] [Abstract][Full Text] [Related]
5. [Use of thrombolytic treatment in patients with acute myocardial infarction in Spain. Observations from the PRIAMHO study].
Bosch X; Sambola A; Arós F; López-Bescós L; Mancisidor X; Illa J; Claramonte R
Rev Esp Cardiol; 2000 Apr; 53(4):490-501. PubMed ID: 10760231
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
Zahn R; Schiele R; Seidl K; Hauptmann KE; Voigtländer T; Rupprecht HJ; Gottwik M; Glunz HG; Senges J
Heart; 1999 Oct; 82(4):420-5. PubMed ID: 10490553
[TBL] [Abstract][Full Text] [Related]
7. Perceived contraindications to thrombolytic treatment in acute myocardial infarction. A survey at a teaching hospital.
Wald DS
J Accid Emerg Med; 1998 Sep; 15(5):329-31. PubMed ID: 9785162
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness of guidelines, audit and feedback: improving the use of intravenous thrombolysis in patients with suspected acute myocardial infarction.
Robinson MB; Thompson E; Black NA
Int J Qual Health Care; 1996 Jun; 8(3):211-22. PubMed ID: 8885185
[TBL] [Abstract][Full Text] [Related]
9. Increased prescription of thrombolytic treatment to elderly patients with suspected acute myocardial infarction associated with audit.
Hendra TJ; Marshall AJ
BMJ; 1992 Feb; 304(6824):423-5. PubMed ID: 1547391
[TBL] [Abstract][Full Text] [Related]
10. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group.
Adams J; Trent R; Rawles J
BMJ; 1993 Aug; 307(6901):409-13. PubMed ID: 8267742
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old.
Soumerai SB; McLaughlin TJ; Ross-Degnan D; Christiansen CL; Gurwitz JH
Arch Intern Med; 2002 Mar; 162(5):561-8. PubMed ID: 11871924
[TBL] [Abstract][Full Text] [Related]
12. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis.
Brown N; Melville M; Gray D; Young T; Skene AM; Wilcox RG; Hampton JR
Heart; 1999 Jun; 81(6):598-602. PubMed ID: 10336917
[TBL] [Abstract][Full Text] [Related]
13. Suspected myocardial infarction and left bundle branch block: electrocardiographic indicators of acute ischaemia.
Edhouse JA; Sakr M; Angus J; Morris FP
J Accid Emerg Med; 1999 Sep; 16(5):331-5. PubMed ID: 10505911
[TBL] [Abstract][Full Text] [Related]
14. Selection of patients with acute myocardial infarction for thrombolytic therapy.
Muller DW; Topol EJ
Ann Intern Med; 1990 Dec; 113(12):949-60. PubMed ID: 2240919
[TBL] [Abstract][Full Text] [Related]
15. Why is evaluation of the cost effectiveness of audit so difficult? The example of thrombolysis for suspected acute myocardial infarction.
Robinson MB; Thompson E; Black NA
Qual Health Care; 1998 Mar; 7(1):19-26. PubMed ID: 10178145
[TBL] [Abstract][Full Text] [Related]
16. Consequences of overutilization and underutilization of thrombolytic therapy in clinical practice. TRACE Study Group. TRAndolapril Cardiac Evaluation.
Ottesen MM; Køber L; Jørgensen S; Torp-Pedersen C
J Am Coll Cardiol; 2001 May; 37(6):1581-7. PubMed ID: 11345368
[TBL] [Abstract][Full Text] [Related]
17. The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP).
Horne S; Weston C; Quinn T; Hicks A; Walker L; Chen R; Birkhead J
Heart; 2009 Apr; 95(7):559-63. PubMed ID: 17923462
[TBL] [Abstract][Full Text] [Related]
18. Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland.
Hood S; Birnie D; Curzio JL; Hillis WS
Health Bull (Edinb); 1996 Mar; 54(2):131-9. PubMed ID: 8655300
[TBL] [Abstract][Full Text] [Related]
19. Presentation, delay, and contraindication to thrombolytic treatment in females and males with myocardial infarction.
Grace SL; Abbey SE; Bisaillon S; Shnek ZM; Irvine J; Stewart DE
Womens Health Issues; 2003; 13(6):214-21. PubMed ID: 14675790
[TBL] [Abstract][Full Text] [Related]
20. Thrombolytic therapy in diabetic patients with acute myocardial infarction.
Hansen HH; Kjaergaard SC; Bülow I; Fog L; Christensen PD
Diabetes Care; 1996 Oct; 19(10):1135-7. PubMed ID: 8886563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
